DUBLIN (AP) — DUBLIN (AP) — Avadel Pharmaceuticals PLC (AVDL) on Wednesday reported a loss of $27.3 million in its first quarter.

On a per-share basis, the Dublin-based company said it had a loss of 30 cents.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The specialty pharmaceutical company posted revenue of $27.2 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $25.1 million.

Avadel shares have increased 29% since the beginning of the year. The stock has climbed 23% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVDL at https://www.zacks.com/ap/AVDL

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News